Aptamer 学术简报 — neurodegeneration — 2026-10-14

自动生成 by RBTX Aptamer Tracker v0.1。 子主题 neurodegeneration：近 14 天 7 篇命中（aptamer 池 205 篇）。

评分公式：composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus；满分 100。

#1 [13.8] Online aptamer-based solid-phase extraction coupled with high-performance liquid chromatography-mass spectrometry for the determination of Alzheimer's disease biomarkers.

BACKGROUND: Reliable quantification of amyloid-β (Aβ) peptides in biological fluids is of major clinical and research interest in Alzheimer disease context. Conventional offline extraction approaches often involve labor-intensive manual steps and high solvent consumption, limiting throughput routine applications, reproducibility, and sustainabil...

#2 [11.6] Label-Free Acoustic Wave Detection of Myelin Basic Protein for Monitoring of Neurodegenerative Disease

Myelin basic protein (MBP) is released into cerebrospinal fluid during demyelination and is therefore a promising biomarker for the detection of neurodegenerative diseases such as multiple sclerosis. For the label-free detection of MBP, we developed an antifouling aptasensor based on thickness shear mode sensing. DNA aptamers were immobilized on...

#3 [9.3] Multiplexed impedimetric zinc oxide nanorods-modified aptasensor on carbon ink-inscribed paper electrodes for the specific and sensitive co-detection of Alzheimer's and Parkinson's disease.

Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), represent a growing health burden, while early diagnosis remains challenging because established diagnostic approaches, including cerebrospinal fluid analysis and neuroimaging, are invasive, expensive, and unsuitable for decentralized point-of-care testi...

#4 [8.7] Computationally guided engineering of an aptamer–gold nanoparticle aptasensor for ultrasensitive detection of α-synuclein in biological matrices

Early, reliable detection of α-synuclein (αSN) is critical for Parkinson's disease diagnosis, yet antibody-based assays remain limited by sensitivity, matrix effects, and cost. We report a label-free aptamer–gold nanoparticle nanobiosensor (G 12 Apt@AuNP) for non-invasive αSN detection in saliva. Molecular docking identified F5R1 as the aptamer ...

#5 [8.0] QR-code‑linked additive-engineered aptasensor for non-invasive impedimetric biosensing of neurodegenerative biomarker Aβ-42 with computational modelling validation for high selectivity

#6 [7.7] Achieving near single-molecule sensitivity in separation-free protein detection using engineered kinetic proofreading

Unlike nucleic acids, proteins cannot be directly amplified. Ultrasensitive detection must therefore couple efficient analyte-to-signal conversion with strong suppression of target-independent background. Consistently detecting ~100 molecules (below which Poisson sampling noise alone causes CV to exceed 10%) across protein targets in a format as...

#7 [5.7] Targeted nanovesicular delivery of dexmedetomidine modulates microglial lysosomal function via Sirt3 signaling to ameliorate neurodegenerative pathology.

Neuroinflammation and lysosomal dysfunction in microglia are increasingly recognized as critical pathological drivers of Alzheimer’s disease, yet current anti-inflammatory or neuroprotective agents have limited brain delivery efficiency and cellular specificity. To address these challenges, this study proposes a novel nanotherapeutic paradigm ba...

Methodology